Geneva / Helsinki / Lima / New York / Washington / DC / Nashville / Miami / London / /
Company
Cambridge University Press / Oxford University Press / /
Continent
Americas / /
Country
Switzerland / Palestinian Authority / Nicaragua / Ecuador / Bahrain / Oman / Tunisia / Guatemala / Mexico / United Arab Emirates / South Africa / Chile / Swaziland / Peru / Honduras / Namibia / Lesotho / Egypt / Norway / Thailand / Colombia / Jordan / El Salvador / United States / Panama / Iceland / Dominican Republic / Australia / Liechtenstein / Botswana / Singapore / Morocco / Argentina / Lebanon / Costa Rica / / /
Facility
University of Buenos Aires / /
IndustryTerm
public law / pharmaceutical product / pharmaceutical patenting / generic product / pharmaceutical / food / manufacturing capacity / pharmaceuticals / pharmt maceutical products / chemical entities / pharmaceutical products / generic products / technology transfer / /
MedicalCondition
malaria / HIV/AIDS / tuberculosis / /
Organization
Cambridge University / World Health Organization / Food and Drug Administration / American Economic Association / national health authority / Free Trade Association / Oxfam / Bush Administration / South Centre / World Trade Organization / University of Buenos Aires / Buenos Aires / Government of South Africa / 16 / Council for TRIPS / United States House of Representatives / U.S. Congress / Commission on Intellectual Property Rights / World Bank / United Nations Development Programme / World Health Assembly / WTO General Council / US Federal Trade Commission / European Union / Oxford University / World Medical Association / /
Person
Carlos María Correa / Marco Referencial / Carlos María Correa Bilateral / /
Public Health Reviews Implications of bilateral free trade agreements on access to medicines Carlos María Correa a Abstract The TRIPS Agreement of the World Trade Organization (WTO) mandated the introduction of protect